FemTech is undergoing its most consequential structural shift since the term was coined in 2016. What began as a cycle-tracking utility is maturing into a precision medicine category spanning hormonal intelligence, AI-powered diagnostics, cardiometabolic care, longevity platforms and regulated medical devices. The global market, valued at approximately USD $9.12 to $9.78 Billion in 2025, is projected to reach USD $10.67 Billion in 2026 and expand to USD $18.98 to 41.14 Billio